DanielRayJonesMD

PubMed

• Death effects of reveromycin A in normal and disease-associated cells of the joint.
  Svrcina, H.,Greer, A.,Baker, S.,Smith, M.,Martinez, P.,Granger, N.,Thomas, N.,Miller, J.,Steinke, E.,Davitt, K.,Sloane, E.,Nugent, L.,Sabo, R.,Williams, C.,Lipton, M. ...> ;J. Cell. Biochem.. 2017 Oct 28
• Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute le...
  Farag SS, Wood LL, Schwartz JE, Srivastava S, Nelson RP, Robertson MJ, Abonour R, Secrest A, Cox E, Baute J, Sullivan C, Kane K, Jones DR> ;Leukemia. 2011-04-01
• Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features.
  Wang SA, Jabbar K, Lu G, Chen SS, Galili N, Vega F, Jones D, Raza A, Kantarjian H, Garcia-Manero G, McDonnell TJ, Medeiros LJ> ;Leukemia. 2010-04-01
• Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia.
  Kaste, S. C.,Thomas, N. A.,Rai, S. N.,Cheon, K.,McCammon, E.,Chesney, R.,Jones, D.,Pui, C. H.,Hudson, M. M.> ;Leukemia. 2008 Oct 03
• Quantitative profiling of codon 816 KIT mutations can aid in the classification of systemic mast cell disease.
  Zhao W, Bueso-Ramos CE, Verstovsek S, Barkoh BA, Khitamy AA, Jones D> ;Leukemia. 2007-07-01
• Dental abnormalities in children treated for acute lymphoblastic leukemia.
  Kaste SC, Hopkins KP, Jones D, Crom D, Greenwald CA, Santana VM> ;Leukemia. 1997-06-01
• Join now to see all